ANGIONAUTIX REACHES AN AGREEMENT WITH ELEVATE SCIENTIFIC TO DISTRIBUTE ABSOLUTE GEL IN SPAIN AND PORTUGAL

READ MORE
La próxima generación de recubrimiento antitrombogénico

HEAL TECHNOLOGY: THE NEXT GENERATION OF ANTITHROMBOGENIC COATING

READ MORE

The first 209 patients were analyzed, with a 72.7% FPE result

READ MORE
El registro AQUAS obtiene la autorización del comité ético para comenzar

The AQUAS registry is currently in the analysis phase of the results after the recruitment of 126 patients

READ MORE

The 0-TICI-0 registry is currently in the analysis phase of the results after the recruitment has been completed.

READ MORE

The countdown begins

0Weeks0Days0Hours0Minutes0Seconds

Neurovascular

division

See more

Cardiovascular

division

See more

Healthcare

Applications

See more

PATHOLOGIES

1
2
3
4
5
6
7
8
NEUROVASCULAR PATHOLOGIES
CARDIOVASCULAR PATHOLOGIES
NEUROVASCULAR PATHOLOGIES
CARDIOVASCULAR PATHOLOGIES

Last news

Angionautix reaches an agreement with Elevate Scientific to distribute Absolute Gel in Spain and Portugal.

Absolute Gel functions as a flexible implant for the treatment of disc herniation (one of the most common causes of chronic back pain) through a minimally invasive percutaneous procedure. From now on, it will benefit thousands of patients in our region.
la próxima generación de recubrimiento antitrombogénico

HEAL Technology: The next generation of antithrombogenic coating

The HEAL Technology mimics the final step of natural haemostasis and thus the conversion of fibrinogen (by thrombin) to fibrin.

Presentation of the BETYS study at the offices of Angionautix S.L.

Dr. Carlos Perez Garcia, neuroradiologist from Clínico San Carlos Hospital (Madrid) presented the BETYS registry at Angionautix Headquarters.

Our brands

 
PreviousNext
12